S. Korea To Spend Millions Promoting Medical-Robot Development
This article was originally published in PharmAsia News
Executive Summary
South Korea plans to spend $8 million to promote an industry to develop the technologies behind medical- and security-related robots so the country can become a leader in the sector. The Ministry of Knowledge Economy said 40 percent of the research-and-development funds would go to Curexo to work with Samsung Medical Center to develop a robot specializing in artificial joint surgery. The other 60 percent is for a company specializing in robots providing industrial security. (Click here for more
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.